The Safety and Efficacy of Switching Timolol Maleate 0.5% Solution to Timolol Hemihydrate 0.5% Solution Given Twice Daily

Journal of Ocular Pharmacology and Therapeutics

Volumn 14, Issue 2, 1998, Pages 129-135

  Mundorf, Thomas K ^a   Gate, Elin A ^b   Sine, Cheryl S ^a   Otero, Donna W ^a   Stewart, Jeanette A ^b   Stewart, William C ^a  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TIMOLOL; TIMOLOL MALEATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EYE TOXICITY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; TOPICAL DRUG ADMINISTRATION; VISUAL ACUITY;

AGED; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; TIMOLOL;

EID: 0031976720     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1998.14.129     Document Type: Article

References (17)

1. Keates, E.U. and Stone, R. The effect of δ-timolol on intraocular pressure in patients with ocular hypertension. Am. J. Ophthalmol., 98:73-78, 1984.
2. Liu, J.H.K., Bartels, S.P., and Neufeld, A.H. Effects of 1- and d-timolol on cyclic AMP synthesis and intraocular pressure in water-loaded, albino and pigmented rabbits. Invest. Ophthalmol. Vis. Sci., 24:1276-1282, 1983.
3. Stewart, W.C. Timolol hemihydrate - a new formulation of timolol for the treatment of glaucoma. J. Ocul. Pharmacol. Ther., 12:225-237, 1996.
4. Dubiner, H.B., Hill, R., Kaufrnan, H., Keates, E.U., Zimmerman, T.J., Mandell, A.I., Mundorf, T.K., Bahr, R.L., Schwartz, L.W., Towey, A.W., Hurvitz, L.M., Starita, R.J., Sassani, J.W., Ropo, A., Gunn, R., and Stewart, W.C. Timolol hemihydrate vs. timolol maleate in ocular hypertension and open-angle glaucoma. Am. J. Ophthalmol., 121:522-528, 1996.
5. Shields, M.B. Textbook of Glaucoma, second edition. Williams & Wilkins, Baltimore, 1987, p. 370.
6. Duff, G.R. A double-masked crossover study comparing the effects of carteolol 1 % and 2% on intraocular pressure. Acta Ophthalmologica, 65:618-621, 1987.
7. Book, S.A. Essentials of statistics. New York: McGraw-Hill Book Company, 1978; pp. 128-131.
8. Rosner, B. Fundamentals of Biostatistics. Duxbury Press, Boston, 1982, pp. 301-304.
9. Siegel, S. Non Parametric Statistics. Series in Psychology. McGraw Hill, New York, 1956, pp. 63-67.
10. Laibovitz, R.A., Dubiner, H.B., Sail, K.N., Mundorf, T.K., Katz, L.J, Singh, K., Shulman, D.G, Siegel, L.I., Nussbaum, L.L., Stewart, W.C. Ocular tolerability and intraocular pressure effects of carteolol and timolol in older women with ocular hypertension or primary open angle glaucoma. Invest. Ophthalmol. Vis. Sei., 38 (suppl):S2586, 1997.
11. Stewart, W.C. and Castelli, W.P. Systemic side effects of topical β-adrenergic blockers. Clin. Cardiol., 19:691-697, 1996.
12. Colley, C.A. and Lucas, L.M. Polypharmacy: The cure becomes the disease. J. Gen. Internal Med, 8:278-283, 1993.
13. Stewart, W.C. Current and future glaucoma therapy. In CIBA Clinical Symposium, CffiA Vision Ophthalmics, Duluth, 1997, pp. 1-43.
14. Stewart, W.C., Sine, C., Gate, E., Minno, G.E., Hunt, H.H. Daily cost of -adrenergic blocker therapy. Arch. Ophthalmol., 115:853-856, 1997.
15. Stewart, W.C. Clinical Practice of Glaucoma. SLACK, Inc., Thorafare, 1990.
16. Stewart, W.C. Carteolol, an ophthalmic β-adrenergic blocker with intrinsic sympathomimetic activity. J. Glaucoma, 3:339-345, 1994.
17. Reprint Requests: William C. Stewart, M.D. Pharmaceutical Research Corporation 1639 Tatum Street Charleston, South Carolina 29412-2646 USA